Table 1:

Patient Characteristics

Patient	Age at Presentation of Chylothorax/Sex	Cytogenetics	IgHV Status	Other prognostic markers	Treatments	Symptoms	Outcome
Patient 1	78/M	13q deletion	Unknown	CD38 (−); Zap70 (−)	Interferon; Cladribine; Pentostatin, Cyclophosphamide and Rituximab; Bendamustine and Rituximab	Shortness of breath	Improvement × 2 years with Bendamustine and Rituxan (2 cycles)
Patient 2	81/F	11q deletion	Unknown	CD38(+)	Bendamustine and Rituxan	Shortness of breath	Marginal improvement after Bendamustine and Rituxan (3 cycles)
Patient 3	77 / F	Unknown	Mutated	Unknown	Obintuzumab × 1 cycle; Idelalisib; 2400 cGy RT	Shortness of breath	Improved after 2400 cGy to thoracic duct and mediastinum

IGHV: immunoglobulin heavy chain variable region genes; RT: radiation therapy.